Deadenylation is a Widespread Effect of MiRNA Regulation
Overview
Affiliations
miRNAs silence gene expression by repressing translation and/or by promoting mRNA decay. In animal cells, degradation of partially complementary miRNA targets occurs via deadenylation by the CAF1-CCR4-NOT1 deadenylase complex, followed by decapping and subsequent exonucleolytic digestion. To determine how generally miRNAs trigger deadenylation, we compared mRNA expression profiles in D. melanogaster cells depleted of AGO1, CAF1, or NOT1. We show that approximately 60% of AGO1 targets are regulated by CAF1 and/or NOT1, indicating that deadenylation is a widespread effect of miRNA regulation. However, neither a poly(A) tail nor mRNA circularization are required for silencing, because mRNAs whose 3' ends are generated by a self-cleaving ribozyme are also silenced in vivo. We show further that miRNAs trigger mRNA degradation, even when binding by 40S ribosomal subunits is inhibited in cis. These results indicate that miRNAs promote mRNA decay by altering mRNP composition and/or conformation, rather than by directly interfering with the binding and function of ribosomal subunits.
An update on the molecular mechanisms underlying the progression of miR-21 in oral cancer.
Prasad M, Hamsa D, Fareed M, Karobari M World J Surg Oncol. 2025; 23(1):73.
PMID: 40025548 PMC: 11871704. DOI: 10.1186/s12957-025-03732-2.
miRNA in blood-brain barrier repair: role of extracellular vesicles in stroke recovery.
Sprincl V, Romanyuk N Front Cell Neurosci. 2025; 19:1503193.
PMID: 39990970 PMC: 11842324. DOI: 10.3389/fncel.2025.1503193.
Niazi S, Magoola M Int J Mol Sci. 2024; 25(23.
PMID: 39684593 PMC: 11641023. DOI: 10.3390/ijms252312883.
Representation of non-coding RNA-mediated regulation of gene expression using the Gene Ontology.
Antonazzo G, Gaudet P, Lovering R, Attrill H RNA Biol. 2024; 21(1):36-48.
PMID: 39374113 PMC: 11459742. DOI: 10.1080/15476286.2024.2408523.
Exploring the role of miRNA in diabetic neuropathy: from diagnostics to therapeutics.
Saha P, Yarra S, Arruri V, Mohan U, Kumar A Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1129-1144.
PMID: 39249503 DOI: 10.1007/s00210-024-03422-y.